Cargando…
Docking cholesterol to integral membrane proteins with Rosetta
Lipid molecules such as cholesterol interact with the surface of integral membrane proteins (IMP) in a mode different from drug-like molecules in a protein binding pocket. These differences are due to the lipid molecule’s shape, the membrane’s hydrophobic environment, and the lipid’s orientation in...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042369/ https://www.ncbi.nlm.nih.gov/pubmed/36972273 http://dx.doi.org/10.1371/journal.pcbi.1010947 |
_version_ | 1784912919513792512 |
---|---|
author | Marlow, Brennica Kuenze, Georg Meiler, Jens Koehler Leman, Julia |
author_facet | Marlow, Brennica Kuenze, Georg Meiler, Jens Koehler Leman, Julia |
author_sort | Marlow, Brennica |
collection | PubMed |
description | Lipid molecules such as cholesterol interact with the surface of integral membrane proteins (IMP) in a mode different from drug-like molecules in a protein binding pocket. These differences are due to the lipid molecule’s shape, the membrane’s hydrophobic environment, and the lipid’s orientation in the membrane. We can use the recent increase in experimental structures in complex with cholesterol to understand protein-cholesterol interactions. We developed the RosettaCholesterol protocol consisting of (1) a prediction phase using an energy grid to sample and score native-like binding poses and (2) a specificity filter to calculate the likelihood that a cholesterol interaction site may be specific. We used a multi-pronged benchmark (self-dock, flip-dock, cross-dock, and global-dock) of protein-cholesterol complexes to validate our method. RosettaCholesterol improved sampling and scoring of native poses over the standard RosettaLigand baseline method in 91% of cases and performs better regardless of benchmark complexity. On the β2AR, our method found one likely-specific site, which is described in the literature. The RosettaCholesterol protocol quantifies cholesterol binding site specificity. Our approach provides a starting point for high-throughput modeling and prediction of cholesterol binding sites for further experimental validation. |
format | Online Article Text |
id | pubmed-10042369 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-100423692023-03-28 Docking cholesterol to integral membrane proteins with Rosetta Marlow, Brennica Kuenze, Georg Meiler, Jens Koehler Leman, Julia PLoS Comput Biol Research Article Lipid molecules such as cholesterol interact with the surface of integral membrane proteins (IMP) in a mode different from drug-like molecules in a protein binding pocket. These differences are due to the lipid molecule’s shape, the membrane’s hydrophobic environment, and the lipid’s orientation in the membrane. We can use the recent increase in experimental structures in complex with cholesterol to understand protein-cholesterol interactions. We developed the RosettaCholesterol protocol consisting of (1) a prediction phase using an energy grid to sample and score native-like binding poses and (2) a specificity filter to calculate the likelihood that a cholesterol interaction site may be specific. We used a multi-pronged benchmark (self-dock, flip-dock, cross-dock, and global-dock) of protein-cholesterol complexes to validate our method. RosettaCholesterol improved sampling and scoring of native poses over the standard RosettaLigand baseline method in 91% of cases and performs better regardless of benchmark complexity. On the β2AR, our method found one likely-specific site, which is described in the literature. The RosettaCholesterol protocol quantifies cholesterol binding site specificity. Our approach provides a starting point for high-throughput modeling and prediction of cholesterol binding sites for further experimental validation. Public Library of Science 2023-03-27 /pmc/articles/PMC10042369/ /pubmed/36972273 http://dx.doi.org/10.1371/journal.pcbi.1010947 Text en © 2023 Marlow et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Marlow, Brennica Kuenze, Georg Meiler, Jens Koehler Leman, Julia Docking cholesterol to integral membrane proteins with Rosetta |
title | Docking cholesterol to integral membrane proteins with Rosetta |
title_full | Docking cholesterol to integral membrane proteins with Rosetta |
title_fullStr | Docking cholesterol to integral membrane proteins with Rosetta |
title_full_unstemmed | Docking cholesterol to integral membrane proteins with Rosetta |
title_short | Docking cholesterol to integral membrane proteins with Rosetta |
title_sort | docking cholesterol to integral membrane proteins with rosetta |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042369/ https://www.ncbi.nlm.nih.gov/pubmed/36972273 http://dx.doi.org/10.1371/journal.pcbi.1010947 |
work_keys_str_mv | AT marlowbrennica dockingcholesteroltointegralmembraneproteinswithrosetta AT kuenzegeorg dockingcholesteroltointegralmembraneproteinswithrosetta AT meilerjens dockingcholesteroltointegralmembraneproteinswithrosetta AT koehlerlemanjulia dockingcholesteroltointegralmembraneproteinswithrosetta |